TTK Healthcare [TTKHLTCARE] vs Pfizer [PFIZER] Detailed Stock Comparison

TTK Healthcare

NSE
Loading...

Pfizer

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: TTK Healthcare wins in 7 metrics, Pfizer wins in 13 metrics, with 0 ties. Pfizer appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTTK HealthcarePfizerBetter
P/E Ratio (TTM)25.7928.68TTK Healthcare
Price-to-Book Ratio1.535.46TTK Healthcare
Debt-to-Equity Ratio2.272.57TTK Healthcare
PEG Ratio-0.441.05TTK Healthcare
EV/EBITDA27.0326.77Pfizer
Profit Margin (TTM)7.69%34.83%Pfizer
Operating Margin (TTM)0.22%32.44%Pfizer
EBITDA Margin (TTM)0.22%32.44%Pfizer
Return on Equity7.67%18.20%Pfizer
Return on Assets (TTM)6.37%15.63%Pfizer
Free Cash Flow (TTM)$-168.16M$6.32BPfizer
Dividend Yield0.74%1.27%Pfizer
1-Year Return-28.09%-8.29%Pfizer
Price-to-Sales Ratio (TTM)1.999.98TTK Healthcare
Enterprise Value$7.74B$197.67BPfizer
EV/Revenue Ratio0.948.52TTK Healthcare
Gross Profit Margin (TTM)55.03%64.97%Pfizer
Revenue per Share (TTM)$580$507TTK Healthcare
Earnings per Share (Diluted)$44.68$175.62Pfizer
Beta (Stock Volatility)0.280.12Pfizer
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

TTK Healthcare vs Pfizer Stock Performance Analysis

Loading Price Chart...

TTK Healthcare
Pfizer
TTK Healthcare Stock Overview | Pfizer Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TTK Healthcare-0.72%-2.66%0.24%-9.50%-1.96%-17.55%
Pfizer1.35%2.92%0.31%-9.61%27.62%-2.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TTK Healthcare-28.09%21.98%161.51%46.44%179.35%308.57%
Pfizer-8.29%16.04%2.57%110.29%370.97%531.64%

News Based Sentiment: TTK Healthcare vs Pfizer

TTK Healthcare

News based Sentiment: MIXED

September presented a mixed bag for TTK Healthcare, with impressive revenue growth overshadowed by a significant drop in profitability and a change in the promoter group. These conflicting signals, coupled with share price volatility, create a complex investment picture requiring careful monitoring of upcoming financial results and leadership developments.

View TTK Healthcare News Sentiment Analysis

Pfizer

News based Sentiment: MIXED

September presented a mixed bag for Pfizer Ltd. While the company demonstrated strong financial performance with impressive Q1 results and launched a new vaccine, the share price experienced a decline and valuation metrics shifted. This combination of positive and negative developments creates a complex investment picture, making it a significant month for investors to assess.

View Pfizer News Sentiment Analysis

Performance & Financial Health Analysis: TTK Healthcare vs Pfizer

MetricTTKHLTCAREPFIZER
Market Information
Market Cap i₹16.28B₹231.58B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,89014,577
90 Day Avg. Volume i3,25618,248
Last Close₹1,150.60₹5,220.50
52 Week Range₹1,101.05 - ₹1,755.00₹3,701.00 - ₹6,020.00
% from 52W High-34.44%-13.28%
All-Time High₹1,893.95 (Sep 09, 2024)₹6,451.15 (Sep 02, 2024)
% from All-Time High-39.25%-19.08%
Growth Metrics
Quarterly Revenue Growth0.09%0.07%
Quarterly Earnings Growth-0.59%0.27%
Financial Health
Profit Margin (TTM) i0.08%0.35%
Operating Margin (TTM) i0.00%0.32%
Return on Equity (TTM) i0.08%0.18%
Debt to Equity (MRQ) i2.272.57
Cash & Liquidity
Book Value per Share (MRQ)₹753.73₹921.88
Cash per Share (MRQ)₹605.17₹608.26
Operating Cash Flow (TTM) i₹338.96M₹9.08B
Levered Free Cash Flow (TTM) i₹816.57M₹7.68B
Dividends
Last 12-Month Dividend Yield i0.74%1.27%
Last 12-Month Dividend i₹10.00₹70.00

Valuation & Enterprise Metrics Analysis: TTK Healthcare vs Pfizer

MetricTTKHLTCAREPFIZER
Price Ratios
P/E Ratio (TTM) i25.7928.68
Forward P/E iN/A30.08
PEG Ratio i-0.441.05
Price to Sales (TTM) i1.999.98
Price to Book (MRQ) i1.535.46
Market Capitalization
Market Capitalization i₹16.28B₹231.58B
Enterprise Value i₹7.74B₹197.67B
Enterprise Value Metrics
Enterprise to Revenue i0.948.52
Enterprise to EBITDA i27.0326.77
Risk & Other Metrics
Beta i0.280.12
Book Value per Share (MRQ) i₹753.73₹921.88

Financial Statements Comparison: TTK Healthcare vs Pfizer

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TTKHLTCAREPFIZER
Revenue/Sales i₹2.26B₹6.03B
Cost of Goods Sold i₹1.02B₹2.11B
Gross Profit i₹1.25B₹3.92B
Research & Development iN/AN/A
Operating Income (EBIT) i₹4.88M₹1.96B
EBITDA i₹206.11M₹2.77B
Pre-Tax Income i₹176.54M₹2.60B
Income Tax i₹46.54M₹677.80M
Net Income (Profit) i₹129.99M₹1.92B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TTKHLTCAREPFIZER
Cash & Equivalents i₹90.06M₹4.95B
Total Current Assets i₹11.04B₹35.13B
Total Current Liabilities i₹2.11B₹5.70B
Long-Term Debt i₹17.73M₹676.20M
Total Shareholders Equity i₹10.65B₹42.17B
Retained Earnings i₹9.40B₹24.36B
Property, Plant & Equipment i₹808.99M₹1.72B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TTKHLTCAREPFIZER
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTTKHLTCAREPFIZER
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,89014,577
Average Daily Volume (90 Day) i3,25618,248
Shares Outstanding i14.13M45.75M
Float Shares i3.27M15.12M
% Held by Insiders i0.77%0.67%
% Held by Institutions i0.03%0.17%

Dividend Analysis & Yield Comparison: TTK Healthcare vs Pfizer

MetricTTKHLTCAREPFIZER
Last 12-Month Dividend i₹10.00₹70.00
Last 12-Month Dividend Yield i0.74%1.27%
3-Year Avg Annual Dividend i₹13.33₹46.67
3-Year Avg Dividend Yield i0.85%0.58%
3-Year Total Dividends i₹40.00₹140.00
Ex-Dividend DateJul 18, 2025Jul 09, 2025